Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Loxapine Succinate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,104Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Actavis Inc

    02 4Elite Laboratories

    03 4Lannett Company, Inc.

    04 3PENDOPHARM DIVISION OF DE PHARMASCIENCE INC

    05 4Rising Pharmaceuticals Inc

    06 7Teva Pharmaceutical Industries

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Actavis Inc

    Ireland
    2024 ACI Convention
    Not Confirmed
    arrow

    Actavis Inc

    Ireland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 50MG BASE

    Packaging :

    Approval Date : 1988-06-15

    Application Number : 72062

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Actavis Inc

    Ireland
    2024 ACI Convention
    Not Confirmed
    arrow

    Actavis Inc

    Ireland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 5MG BASE

    Packaging :

    Approval Date : 1988-06-15

    Application Number : 72204

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Actavis Inc

    Ireland
    2024 ACI Convention
    Not Confirmed
    arrow

    Actavis Inc

    Ireland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 10MG BASE

    Packaging :

    Approval Date : 1988-06-15

    Application Number : 72205

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Actavis Inc

    Ireland
    2024 ACI Convention
    Not Confirmed
    arrow

    Actavis Inc

    Ireland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 1988-06-15

    Application Number : 72206

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Elite Laboratories

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Elite Laboratories

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 5MG BASE

    Packaging :

    Approval Date : 2005-08-04

    Application Number : 76868

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Elite Laboratories

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Elite Laboratories

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 10MG BASE

    Packaging :

    Approval Date : 2005-08-04

    Application Number : 76868

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Elite Laboratories

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Elite Laboratories

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2005-08-04

    Application Number : 76868

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Elite Laboratories

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Elite Laboratories

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 50MG BASE

    Packaging :

    Approval Date : 2005-08-04

    Application Number : 76868

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Lannett Company, Inc.

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Lannett Company, Inc.

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 5MG BASE

    Packaging :

    Approval Date : 2011-09-26

    Application Number : 90695

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Rising Pharmaceuticals Inc

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 5MG BASE

    Packaging :

    Approval Date : 2004-11-01

    Application Number : 76762

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Rising Pharmaceuticals Inc

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 10MG BASE

    Packaging :

    Approval Date : 2004-11-01

    Application Number : 76762

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Rising Pharmaceuticals Inc

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2004-11-01

    Application Number : 76762

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    Rising Pharmaceuticals Inc

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXAPINE SUCCINATE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 50MG BASE

    Packaging :

    Approval Date : 2004-11-01

    Application Number : 76762

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Teva Pharmaceutical Industries

    Israel
    2024 ACI Convention
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXITANE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 17525

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Teva Pharmaceutical Industries

    Israel
    2024 ACI Convention
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXITANE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 17525

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Teva Pharmaceutical Industries

    Israel
    2024 ACI Convention
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXITANE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 17525

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Teva Pharmaceutical Industries

    Israel
    2024 ACI Convention
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXITANE

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 17525

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Teva Pharmaceutical Industries

    Israel
    2024 ACI Convention
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXITANE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 10MG BASE **Federal Register determination that product was discontinued or withdrawn for s or e reasons**

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 17525

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    Teva Pharmaceutical Industries

    Israel
    2024 ACI Convention
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXITANE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 17525

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    Teva Pharmaceutical Industries

    Israel
    2024 ACI Convention
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    LOXAPINE SUCCINATE

    Brand Name : LOXITANE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 17525

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF